TY - JOUR
T1 - siRNA delivery using nanocarriers - An efficient tool for gene silencing
AU - Khurana, Bharat
AU - Goyal, Amit K.
AU - Budhiraja, Abhishek
AU - Arora, Daisy
AU - Vyas, Suresh P.
N1 - Generated from Scopus record by KAUST IRTS on 2023-10-12
PY - 2010/4/1
Y1 - 2010/4/1
N2 - Small interfering RNAs (siRNA) are one of the most recent additions used to silence gene expression. At present, siRNA is the most extensively used gene-silencing technique over other nucleic-acid based approaches to treat diseases including cancer, hepatitis, respiratory disease, cardiovascular diseases, neuronal disease and autoimmune disease. However, systemic delivery of siRNA remains to be the biggest challenge to be overcome. Various strategies have been developed to deliver siRNA efficiently into target cell such as chemical modification of siRNA, physical strategies, viral and non viral-vectors mediated delivery. Among all the approaches non viral vectors including lipoplexes, polyplexes and inorganic nanoparticles were found to be most successful which have been reviewed in this article. Further therapeutic applications of RNAi have also been briefly reviewed. © 2010 Bentham Science Publishers Ltd.
AB - Small interfering RNAs (siRNA) are one of the most recent additions used to silence gene expression. At present, siRNA is the most extensively used gene-silencing technique over other nucleic-acid based approaches to treat diseases including cancer, hepatitis, respiratory disease, cardiovascular diseases, neuronal disease and autoimmune disease. However, systemic delivery of siRNA remains to be the biggest challenge to be overcome. Various strategies have been developed to deliver siRNA efficiently into target cell such as chemical modification of siRNA, physical strategies, viral and non viral-vectors mediated delivery. Among all the approaches non viral vectors including lipoplexes, polyplexes and inorganic nanoparticles were found to be most successful which have been reviewed in this article. Further therapeutic applications of RNAi have also been briefly reviewed. © 2010 Bentham Science Publishers Ltd.
UR - http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1566-5232&volume=10&issue=2&spage=139
UR - http://www.scopus.com/inward/record.url?scp=77950929285&partnerID=8YFLogxK
U2 - 10.2174/156652310791111010
DO - 10.2174/156652310791111010
M3 - Article
SN - 1566-5232
VL - 10
SP - 139
EP - 155
JO - Current Gene Therapy
JF - Current Gene Therapy
IS - 2
ER -
